See more : Prospect Commodities Limited (PCL.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Link-Asia International MedTech Group Limited (1143.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Link-Asia International MedTech Group Limited, a leading company in the Consumer Electronics industry within the Technology sector.
- Innovaro, Inc. (INNI) Income Statement Analysis – Financial Results
- Reddit, Inc. (RDDT) Income Statement Analysis – Financial Results
- Abonmax Co., Ltd (2429.TW) Income Statement Analysis – Financial Results
- Shengkai Innovations, Inc. (VALV) Income Statement Analysis – Financial Results
- CM Life Sciences, Inc. (CMLF) Income Statement Analysis – Financial Results
Link-Asia International MedTech Group Limited (1143.HK)
About Link-Asia International MedTech Group Limited
Link-Asia International MedTech Group Limited, an investment holding company, provides electronic manufacturing services (EMS) for the telecommunications, security, car electronics, home appliances, other consumer, and industrial electronic products. The company operates through four segments: EMS, Distribution of Communications Products, Securities and Other Assets Investment, and Real Estate Supply Chain Services. It is also involved in the trade of personal care products, business telephone systems, and telecommunication products; manufacture and sale of telecommunications and other products, and consumable electronic products; sale of audio equipment; and provision of consultancy services, as well as pre-pregnancy care and assisted reproductive services. In addition, the company offers equity investment and property agency services; and real estate advisory and purchase services. It operates in the People's Republic of China, the United States, Switzerland, France, Poland, the United Kingdom, Belgium, Russia, Thailand, Malaysia, Brazil, and internationally. The company was formerly known as Link-Asia International Co. Ltd. and changed its name to Link-Asia International MedTech Group Limited in December 2020. Link-Asia International MedTech Group Limited was founded in 1992 and is headquartered in Tsim Sha Tsui, Hong Kong.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 502.00M | 529.25M | 675.52M | 595.02M | 629.95M | 681.48M | 662.21M | 748.75M | 1.01B | 1.03B | 1.83B | 1.46B | 1.31B | 1.15B | 821.90M |
| Cost of Revenue | 365.13M | 427.86M | 530.64M | 440.31M | 494.11M | 534.21M | 497.79M | 598.84M | 796.47M | 807.48M | 1.45B | 1.18B | 1.04B | 892.93M | 634.17M |
| Gross Profit | 136.87M | 101.40M | 144.89M | 154.71M | 135.84M | 147.27M | 164.42M | 149.91M | 212.09M | 225.48M | 373.26M | 281.33M | 269.33M | 252.61M | 187.73M |
| Gross Profit Ratio | 27.26% | 19.16% | 21.45% | 26.00% | 21.56% | 21.61% | 24.83% | 20.02% | 21.03% | 21.83% | 20.45% | 19.29% | 20.57% | 22.05% | 22.84% |
| Research & Development | 13.21M | 14.51M | 15.01M | 13.95M | 17.66M | 19.86M | 24.23M | 29.55M | 33.64M | 35.81M | 45.33M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 88.78M | 105.04M | 153.23M | 178.16M | 179.41M | 182.51M | 151.49M | 131.42M | 76.57M | 75.30M | 132.88M | 125.38M | 91.56M | 79.09M | 53.00M |
| Selling & Marketing | 37.99M | 29.99M | 29.23M | 56.32M | 28.83M | 27.53M | 45.58M | 49.94M | 55.37M | 65.90M | 125.55M | 91.52M | 79.52M | 73.02M | 39.85M |
| SG&A | 126.76M | 143.96M | 196.08M | 278.19M | 266.15M | 209.57M | 197.07M | 181.36M | 133.13M | 141.20M | 279.17M | 216.89M | 171.09M | 152.11M | 92.85M |
| Other Expenses | -14.50M | 2.89M | 285.00K | 348.00K | 166.00K | 12.00K | 286.00K | 535.00K | 1.45M | 318.00K | 0.00 | 30.87M | 21.23M | 27.62M | 10.14M |
| Operating Expenses | 125.47M | 158.47M | 210.80M | 291.79M | 283.65M | 218.83M | 277.38M | 221.79M | 163.86M | 163.79M | 323.44M | 247.76M | 192.31M | 179.72M | 102.98M |
| Cost & Expenses | 490.61M | 586.32M | 741.43M | 732.10M | 777.76M | 753.04M | 775.17M | 820.62M | 960.33M | 971.27M | 1.78B | 1.42B | 1.23B | 1.07B | 737.15M |
| Interest Income | 12.68M | 4.19M | 6.33M | 6.62M | 8.34M | 5.80M | 8.45M | 4.09M | 4.32M | 6.41M | 12.28M | 280.00K | 235.00K | 0.00 | 0.00 |
| Interest Expense | 3.07M | 4.05M | 4.17M | 4.93M | 6.81M | 2.78M | 13.05M | 4.30M | 6.08M | 15.87M | 13.30M | 10.85M | 8.39M | 4.43M | 947.00K |
| Depreciation & Amortization | 29.10M | 30.31M | 35.04M | 48.30M | 57.25M | 17.39M | 15.78M | 18.45M | 32.78M | 35.51M | 33.62M | 31.28M | 23.21M | 20.54M | 16.78M |
| EBITDA | 40.49M | -14.06M | -4.54M | -116.52M | -99.23M | -45.59M | -92.59M | -53.22M | 84.63M | 87.12M | 86.08M | 65.13M | 100.23M | 93.43M | 103.12M |
| EBITDA Ratio | 8.07% | -5.06% | -4.57% | -14.92% | -14.38% | -8.82% | -6.01% | -4.93% | 8.39% | 8.43% | 4.72% | 4.47% | 7.65% | 8.16% | 12.55% |
| Operating Income | 11.39M | -57.07M | -65.91M | -137.08M | -147.81M | -77.52M | -55.56M | -55.33M | 51.85M | 51.61M | 52.46M | 33.85M | 77.02M | 72.89M | 84.75M |
| Operating Income Ratio | 2.27% | -10.78% | -9.76% | -23.04% | -23.46% | -11.37% | -8.39% | -7.39% | 5.14% | 5.00% | 2.87% | 2.32% | 5.88% | 6.36% | 10.31% |
| Total Other Income/Expenses | -3.07M | -4.05M | -3.07M | -17.55M | -6.81M | -2.78M | -13.05M | -4.30M | -6.20M | 3.67M | -13.43M | -10.85M | -8.39M | -4.43M | 649.00K |
| Income Before Tax | 8.33M | -48.42M | -43.75M | -169.75M | -163.29M | -65.76M | -121.41M | -75.96M | 43.92M | 55.28M | 37.55M | 23.00M | 68.63M | 68.47M | 85.40M |
| Income Before Tax Ratio | 1.66% | -9.15% | -6.48% | -28.53% | -25.92% | -9.65% | -18.33% | -10.15% | 4.35% | 5.35% | 2.06% | 1.58% | 5.24% | 5.98% | 10.39% |
| Income Tax Expense | 3.16M | 3.59M | 3.40M | 3.32M | 1.30M | 566.00K | 9.90M | 11.07M | 5.55M | 8.14M | 6.14M | 3.51M | 8.12M | 12.75M | 12.73M |
| Net Income | 5.26M | -54.04M | -46.40M | -173.05M | -171.74M | -73.88M | -128.43M | -82.65M | 77.59M | 89.99M | 28.57M | 23.35M | 57.05M | 69.92M | 76.22M |
| Net Income Ratio | 1.05% | -10.21% | -6.87% | -29.08% | -27.26% | -10.84% | -19.39% | -11.04% | 7.69% | 8.71% | 1.56% | 1.60% | 4.36% | 6.10% | 9.27% |
| EPS | 0.03 | -0.50 | -0.78 | -4.50 | -5.63 | -2.49 | -5.02 | -3.34 | 3.12 | 4.37 | 1.39 | 1.11 | 2.76 | 4.55 | 4.95 |
| EPS Diluted | 0.03 | -0.50 | -0.78 | -4.50 | -5.63 | -2.49 | -5.02 | -3.34 | 3.12 | 4.37 | 1.39 | 1.11 | 2.76 | 4.55 | 4.95 |
| Weighted Avg Shares Out | 171.82M | 108.17M | 59.53M | 38.47M | 30.48M | 29.73M | 25.60M | 24.78M | 24.87M | 20.59M | 20.59M | 21.11M | 20.66M | 15.38M | 15.38M |
| Weighted Avg Shares Out (Dil) | 171.82M | 108.17M | 59.53M | 38.47M | 30.48M | 29.73M | 25.60M | 24.78M | 24.87M | 20.59M | 20.59M | 21.11M | 20.66M | 15.38M | 15.38M |
Source: https://incomestatements.info
Category: Stock Reports